QualityStocksNewsBreaks Archives - Page 496 of 1513

ThursdayJul 14, 2022 2:11 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Enabling Commercial Property Owners to Benefit from Global Transition to Clean Energy

Correlate Infrastructure Partners (OTCQB: CIPI) recently launched its Correlate Portfolio Health Program, set to be executed in partnership with Abundant IoT, a worldwide provider of technology aggregation services focused on the internet of things (“IoT”) and energy services. The program seeks to develop a revenue-generation avenue for commercial real estate owners, thereby affording them new revenue and rent opportunities from their current energy assets. “Together, Abundant IoT and Correlate seek to reduce friction between property owners and service providers… The Portfolio Health Program will start with a portfolio health assessment. Once completed, Correlate and Abundant IoT will design, develop and…

ThursdayJul 14, 2022 1:58 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views

Aditxt (NASDAQ: ADTX) provides the AditxtScore(TM), a proprietary immune mapping technology designed to provide a personalized profile of the immune system. “Licensed from Stanford University, AditxtScore(TM) for COVID-19 is Aditxt’s first commercial product. It enables patients to know the level of protection that an immune response to the SARS-CoV-2 virus or vaccination confers them…The results may also influence the vaccine-hesitant populace to take the vaccine, particularly when it is determined that they are not protected by antibodies. Generally, the AditxtScore(TM) results offer information on whether an individual has antibodies that will protect them against the virus; if the antibodies are…

ThursdayJul 14, 2022 1:47 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Benefiting from ‘Snowballing’ Fresh Frozen Cannabis Market

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, recently announced the first transaction under its contract with Cannabis Global Inc. (OTC: CBGL). “The transaction calls for Sugarmade to produce an estimated 25,000 pounds of Fresh Frozen cannabis, which Cannabis Global will use in its product lines and will distribute to the California marketplace. Sugarmade and Cannabis Global have signed a prebooked, fixed-price contract in the amount of $700,000…” a recent article reads. This comes as a growing number of cannabis consumers are choosing Fresh Frozen cannabis, which is flash frozen immediately after harvest instead of undergoing the…

ThursdayJul 14, 2022 1:35 pm

QualityStocksNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Positioned Amid Expected Growth of Indoor Air Quality Market

Kronos Advanced Technologies (OTC: KNOS) is committed to providing the best air-purification devices and products on the market. This comes amid projections that the indoor air quality market will see significant growth in the coming years. “The expanding variety of pollutants is one of the primary factors driving market expansion. The number of regulations and regulatory agencies, such as the United States Environmental Protection Agency (‘EPA’), is also growing to support the market’s expansion,” reads a recent article that contains excerpts from a PRNews report. Another EPA report indicates that the concentrations of some pollutants are often two to five…

ThursdayJul 14, 2022 1:03 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awarded Patent in Japan, Submits Briefing Book

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, announced that it has been notified that it will be awarded a new patent in Japan, which makes the 26th world patent for the company. The patent, which is the third one granted in Japan, recognizes the company’s patented drug-delivery technology, DehydraTECH(TM), and its ability to deliver active pharmaceutical ingredients (“APIs”) more efficiently, regardless of the “food effect,” or the presence of food in the gastrointestinal system. Drug delivery is a key component of reliable drug dosing. According to the announcement, this is the first patent issued from Lexaria’s seventh…

ThursdayJul 14, 2022 11:19 am

QualityStocksNewsBreaks – Odyssey Health Inc.’s (ODYY) Spokesperson Brett Favre to Be Featured on RedChip Money Report(R)

Odyssey Health (OTC: ODYY), f/k/a Odyssey Group International Inc., will be featured in a new interview aired by RedChip Companies on The RedChip Money Report(R) on Bloomberg TV at 7 p.m. Eastern Time this Saturday, July 16. Bloomberg TV is available in an estimated 73 million homes across the U.S. In the exclusive interview, Odyssey Health’s spokesperson and Pro Football Hall of Fame quarterback Brett Favre discusses the major concussion he sustained in the final play of his professional career. Favre will share why he is proudly working to reduce and prevent concussions, the potential of Odyssey’s concussion treatment, and…

ThursdayJul 14, 2022 11:09 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Completion of Partial Interest in Alberta-Based RNG Facility

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has completed the acquisition of a 67% interest in Grow the Energy Circle Ltd. (GrowTEC), a multi-faceted bioenergy venture of sustainable agriculture located in Alberta. Located on the Perry Family farm, GrowTEC integrates responsible best practices and renewable energy. The operating farm-scale biogas facility features an anaerobic digester that converts biodegradable waste into biogas, generating renewable power. With the acquisition now complete, EverGen plans on working with GrowTEC to add on and upgrade the facility; currently the project has an agreement with FortisBC to contribute to its target to…

WednesdayJul 13, 2022 4:07 pm

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing next-generation targeted therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (“CycloSam(R)”), for the treatment of cancer and related diseases. The company today announced that the United States Patent & Trademark Office has granted a key patent protecting how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and provides for high purity in an efficient, facile and reproducible process at lower costs. “This patent issuance marks our third granted patent in the United States and further strengthens our IP estate, consisting of 14…

WednesdayJul 13, 2022 2:56 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Featured in Stock2Me Podcast Spotlighting Two-Time Olympic Gold Medalist Abby Wambach

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products, is featured in the latest episode of InvestorBrandNetwork’s Stock2Me podcast. Hosted by Stuart Smith, the podcast talks with soccer play Abby Wambach, an Olympic gold medalist and member of ODYY’s sports advisory board. During the interview, Wambach discusses her soccer career and why she was drawn to Odyssey, a medical technology company that is developing a drug/device combination intended to treat concussion. Wambach and other members of the sports advisory board support the company’s efforts to enhance public awareness of traumatic brain…

WednesdayJul 13, 2022 2:37 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Nearing Start Date for Its Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the pending start of its upcoming human nicotine study NIC-H22-1. Through the study, Lexaria expects to evidence that processing purified nicotine with its patented drug delivery technology, DehydraTECH(TM), leads to enhanced oral-tissue absorption and reduced negative experiences. NIC-H22-1, a minimum 36-person human pharmacokinetic (“PK”) randomized, double blinded, cross-over study, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the U.S. such as ON! and Zyn. The primary objective of the study is data collection from blood samples that will evidence…

Site Search

Company Search

Category: QualityStocksNewsBreaks